This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ heparin

AI Engines For more Details: PerplexityKagi LabsYou

  1. Anticoagulant Effects:

    • Heparin works by enhancing the activity of antithrombin III, a natural inhibitor of clotting factors such as thrombin and factor Xa. By doing so, heparin prevents the formation of blood clots and helps to inhibit the progression of existing clots.
  2. Medical Uses:

    • Heparin is primarily used for the prevention and treatment of various medical conditions related to abnormal blood clotting, including:
      • Deep vein thrombosis (DVT)
      • Pulmonary embolism (PE)
      • Stroke
      • Myocardial infarction (heart attack)
      • Atrial fibrillation
      • Thrombosis associated with certain medical procedures, such as surgery or hemodialysis
    • It is also used during surgeries to prevent clot formation.
  3. Administration:

    • Heparin is typically administered by injection, either subcutaneously (under the skin) or intravenously (directly into a vein). Injectable forms like Lovenox (enoxaparin) are more commonly used due to their ease of administration and predictable effects.
    • Sublingual heparin, while not as common, may be used in certain situations where rapid anticoagulation is needed.
  4. Side Effects:

    • Common side effects of heparin may include:
      • Bleeding or bruising at the injection site
      • Blood in the urine or stool
      • Nausea or vomiting
      • Hair loss (with long-term use)
    • Serious side effects, such as allergic reactions or heparin-induced thrombocytopenia (HIT), can occur but are less common.
  5. Monitoring:

    • Patients receiving heparin therapy require regular monitoring of blood clotting parameters, such as activated partial thromboplastin time (aPTT) or anti-Xa activity, to ensure that the desired level of anticoagulation is achieved without increasing the risk of bleeding complications.
  6. Dosing:

    • The dosage of heparin is individualized based on factors such as the patient's weight, medical condition, and kidney function. The goal is to achieve therapeutic anticoagulation while minimizing the risk of bleeding.
  7. Reversal:

    • In the event of bleeding complications or the need for urgent surgery, heparin's anticoagulant effects can be rapidly reversed using antidotes such as protamine sulfate.
  8. Precautions:

    • Heparin should be used with caution in patients with a history of bleeding disorders, severe liver or kidney disease, or uncontrolled hypertension.
    • It is contraindicated in patients with active bleeding, certain types of stroke, or a known hypersensitivity to heparin.
  9. Pregnancy and Breastfeeding:

    • Heparin is generally considered safe for use during pregnancy and breastfeeding, as it does not cross the placenta or pass into breast milk in significant amounts.
  10. Drug Interactions:

    • Heparin may interact with other medications, particularly those that affect blood clotting or platelet function. It is important for healthcare providers to review a patient's medication list before prescribing heparin to avoid potential interactions.
;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of heparin On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Increases
species Bacteroides uniformis Reduces

Bacteria Impacted by heparin

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
1 0 Prevotellaceae family Decreases
0 1 Bacteroidaceae family Decreases
0 1 Candidatus Saccharimonadaceae family Decreases
0 1 Eggerthellaceae family Decreases
0 1 Lachnospiraceae family Decreases
0 1 Oscillospiraceae family Decreases
0 1 Desulfovibrionaceae family Decreases
0 1 Rikenellaceae family Increases
0 1 Sutterellaceae family Increases
0 1 Akkermansiaceae family Increases
1 0 Bacteroides genus Decreases
1 0 Bilophila genus Decreases
1 0 Candidatus Saccharimonas genus Decreases
1 0 Enterorhabdus genus Decreases
1 0 Intestinimonas genus Decreases
1 0 Lachnoclostridium genus Decreases
1 0 Ruminiclostridium genus Decreases
0 1 Leyella genus Decreases
0 1 Segatella genus Decreases
0 1 Prevotella genus Decreases
0 1 Paraprevotella genus Decreases
0 1 Alloprevotella genus Decreases
0 1 Hallella genus Decreases
0 1 Marseilla genus Decreases
0 1 Massiliprevotella genus Decreases
0 1 Metaprevotella genus Decreases
0 1 Mycoplasmoides genus Decreases
0 1 Prevotellamassilia genus Decreases
0 1 Hoylesella genus Decreases
0 1 Pseudoprevotella genus Decreases
1 0 Akkermansia genus Increases
1 0 Alistipes genus Increases
1 0 Parasutterella genus Increases
0 1 environmental samples no rank Decreases
0 1 environmental samples no rank Decreases
0 1 environmental samples no rank Decreases
0 1 environmental samples no rank Decreases
0 1 environmental samples no rank Decreases
0 1 environmental samples no rank Decreases
0 1 Eubacteriales incertae sedis no rank Decreases
0 1 unclassified Bacteroides no rank Decreases
0 1 unclassified Bilophila no rank Decreases
0 1 unclassified Candidatus Saccharimonas no rank Decreases
0 1 unclassified Enterorhabdus no rank Decreases
0 1 unclassified Intestinimonas no rank Decreases
0 1 unclassified Lachnoclostridium no rank Decreases
0 1 unclassified Prevotellaceae no rank Decreases
0 1 unclassified Ruminiclostridium no rank Decreases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 unclassified Akkermansia no rank Increases
0 1 unclassified Alistipes no rank Increases
0 1 unclassified Parasutterella no rank Increases
0 1 Bacteroidales order Decreases
0 1 Bacteroides bouchesdurhonensis QSV445 Decreases
0 1 Bilophila wadsworthia species Decreases
0 1 Candidatus Saccharimonas aalborgensis species Decreases
0 1 Intestinimonas butyriciproducens species Decreases
0 1 [Clostridium] scindens species Decreases
1 0 Mycoplasmoides pneumoniae species Decreases
0 1 Ruminiclostridium cellulolyticum species Decreases
0 1 Ruminiclostridium papyrosolvens species Decreases
0 1 [Clostridium] aminophilum species Decreases
0 1 [Clostridium] fimetarium species Decreases
0 1 [Clostridium] herbivorans species Decreases
0 1 [Clostridium] methoxybenzovorans species Decreases
0 1 [Clostridium] polysaccharolyticum species Decreases
0 1 [Clostridium] symbiosum species Decreases
0 1 Alistipes obesi species Decreases
0 1 Bacteroides acidifaciens species Decreases
0 1 Bacteroides caecigallinarum species Decreases
0 1 Bacteroides caecimuri species Decreases
0 1 Bacteroides chinchillae species Decreases
0 1 Bacteroides clarus species Decreases
0 1 Bacteroides congonensis species Decreases
0 1 Bacteroides cutis species Decreases
0 1 Bacteroides denticanum species Decreases
0 1 Bacteroides difficilis species Decreases
0 1 Bacteroides faecalis species Decreases
0 1 Bacteroides faecichinchillae species Decreases
0 1 Bacteroides finegoldii species Decreases
0 1 Bacteroides fluxus species Decreases
0 1 Bacteroides galacturonicus species Decreases
0 1 Bacteroides gallinaceum species Decreases
0 1 Bacteroides gallinarum species Decreases
0 1 Bacteroides graminisolvens species Decreases
0 1 Bacteroides ihuae species Decreases
0 1 Bacteroides ilei species Decreases
0 1 Bacteroides koreensis species Decreases
0 1 Bacteroides kribbi species Decreases
0 1 Bacteroides luti species Decreases
0 1 Bacteroides mediterraneensis species Decreases
0 1 Bacteroides muris (ex Fokt et al. 2023) species Decreases
0 1 Bacteroides ndongoniae species Decreases
0 1 Bacteroides oleiciplenus species Decreases
0 1 Bacteroides parvus species Decreases
0 1 Bacteroides propionicifaciens species Decreases
0 1 Bacteroides propionicigenes species Decreases
0 1 Bacteroides pyogenes species Decreases
0 1 Bacteroides reticulotermitis species Decreases
0 1 Bacteroides rhinocerotis species Decreases
0 1 Bacteroides rodentium species Decreases
0 1 Bacteroides sp species Decreases
0 1 Bacteroides sp. C13EG172 species Decreases
0 1 Bacteroides stercorirosoris species Decreases
0 1 Bacteroides timonensis species Decreases
0 1 Candidatus Bacteroides intestinigallinarum species Decreases
0 1 Candidatus Bilophila faecipullorum species Decreases
0 1 Candidatus Intestinimonas pullistercoris species Decreases
0 1 Candidatus Intestinimonas stercoravium species Decreases
0 1 Candidatus Intestinimonas stercorigallinarum species Decreases
0 1 Candidatus Lachnoclostridium avicola species Decreases
0 1 Enterocloster hominis (ex Hitch et al. 2024) species Decreases
0 1 Intestinimonas aquisgranensis species Decreases
0 1 Intestinimonas gabonensis species Decreases
0 1 Intestinimonas massiliensis (ex Afouda et al. 2020) species Decreases
0 1 Intestinimonas timonensis species Decreases
0 1 Lachnoclostridium edouardi species Decreases
0 1 Ruminiclostridium cellobioparum species Decreases
0 1 Ruminiclostridium hungatei species Decreases
0 1 Ruminiclostridium josui species Decreases
0 1 Ruminiclostridium sufflavum species Decreases
0 1 Bacteroides ovatus species Decreases
0 1 Bacteroides uniformis species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Bacteroides fragilis species Decreases
0 1 Bacteroides xylanisolvens species Decreases
0 1 Bacteroides thetaiotaomicron species Decreases
0 1 Bacteroides caecimuris species Decreases
0 1 Bacteroides humanifaecis species Decreases
0 1 Bacteroides faecium species Decreases
0 1 Ruminiclostridium herbifermentans species Decreases
0 1 Bacteroides salyersiae species Decreases
0 1 Bacteroides faecis species Decreases
0 1 Bacteroides helcogenes species Decreases
0 1 Bacteroides eggerthii species Decreases
0 1 Bacteroides caccae species Decreases
0 1 Bacteroides intestinalis species Decreases
0 1 Bacteroides cellulosilyticus species Decreases
0 1 Bacteroides stercoris species Decreases
0 1 Bacteroides nordii species Decreases
0 1 Lachnoclostridium phytofermentans species Decreases
0 1 Bacteroides zhangwenhongii species Decreases
0 1 Bacteroides heparinolyticus species Decreases
0 1 Bacteroides coprosuis species Decreases
0 1 Bacteroides zoogleoformans species Decreases
0 1 Akkermansia glycaniphila species Increases
0 1 Alistipes megaguti species Increases
0 1 Alistipes indistinctus species Increases
0 1 Alistipes dispar species Increases
0 1 Alistipes ihumii species Increases
0 1 Akkermansia massiliensis species Increases
0 1 Alistipes hominis species Increases
0 1 Alistipes inops species Increases
0 1 Alistipes massiliensis species Increases
0 1 Alistipes montrealensis species Increases
0 1 Alistipes provencensis species Increases
0 1 Alistipes putredinis species Increases
0 1 Alistipes timonensis species Increases
0 1 Candidatus Akkermansia intestinavium species Increases
0 1 Candidatus Alistipes avistercoris species Increases
0 1 Candidatus Alistipes cottocaccae species Increases
0 1 Candidatus Alistipes excrementavium species Increases
0 1 Candidatus Alistipes excrementigallinarum species Increases
0 1 Candidatus Alistipes excrementipullorum species Increases
0 1 Candidatus Alistipes faecigallinarum species Increases
0 1 Candidatus Alistipes intestinigallinarum species Increases
0 1 Candidatus Alistipes merdavium species Increases
0 1 Candidatus Alistipes merdipullorum species Increases
0 1 Candidatus Alistipes pullicola species Increases
0 1 Candidatus Alistipes pullistercoris species Increases
0 1 Candidatus Alistipes stercorigallinarum species Increases
0 1 Candidatus Alistipes stercoripullorum species Increases
0 1 Candidatus Parasutterella gallistercoris species Increases
0 1 Parasutterella excrementihominis species Increases
0 1 Parasutterella secunda species Increases
0 1 Alistipes senegalensis species Increases
0 1 Alistipes shahii species Increases
0 1 Alistipes communis species Increases
0 1 Alistipes finegoldii species Increases
0 1 Alistipes onderdonkii species Increases
0 1 Akkermansia muciniphila species Increases

Impact of heparin on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 1 1
Acne 0.8 0.3 1.67
ADHD 1.4 1.6 -0.14
Age-Related Macular Degeneration and Glaucoma 0.5 -0.5
Allergic Rhinitis (Hay Fever) 1.8 1.2 0.5
Allergies 4 2.8 0.43
Allergy to milk products 1.4 1.9 -0.36
Alopecia (Hair Loss) 0.7 1 -0.43
Alzheimer's disease 4.2 6.8 -0.62
Amyotrophic lateral sclerosis (ALS) Motor Neuron 3.1 1.4 1.21
Ankylosing spondylitis 3.5 2.4 0.46
Anorexia Nervosa 0.8 1.5 -0.88
Antiphospholipid syndrome (APS) 0.7 0.5 0.4
Asthma 3.7 1.2 2.08
Atherosclerosis 2.1 2.1
Atrial fibrillation 2.1 2.5 -0.19
Autism 6.7 6.1 0.1
Autoimmune Disease 0.5 0.5
benign prostatic hyperplasia 0.7 -0.7
Biofilm 0.5 0.5
Bipolar Disorder 2.4 1.1 1.18
Brain Trauma 0.3 1.6 -4.33
Breast Cancer 0.5 0.5
Cancer (General) 0.4 0.1 3
Carcinoma 2.7 1.3 1.08
Celiac Disease 3.3 2.6 0.27
Cerebral Palsy 1.4 1.4 0
Chronic Fatigue Syndrome 3.2 2.2 0.45
Chronic Kidney Disease 2 1.8 0.11
Chronic Lyme 0.5 0.5 0
Chronic Obstructive Pulmonary Disease (COPD) 1.1 1.3 -0.18
Chronic Urticaria (Hives) 0.6 0.6 0
Coagulation / Micro clot triggering bacteria 0.8 0.5 0.6
Cognitive Function 3.2 0.6 4.33
Colorectal Cancer 2.8 5.2 -0.86
Constipation 1.3 0.9 0.44
Coronary artery disease 1.1 1.3 -0.18
COVID-19 7.3 6.1 0.2
Crohn's Disease 5.4 3.5 0.54
Cushing's Syndrome (hypercortisolism) 0.5 -0.5
cystic fibrosis 0.7 -0.7
deep vein thrombosis 0.4 1 -1.5
Depression 7.3 6.5 0.12
Dermatomyositis 0.8 0.8
Eczema 0.6 0.2 2
Endometriosis 1.4 0.6 1.33
Eosinophilic Esophagitis 0.4 0.4
Epilepsy 3.2 3.1 0.03
erectile dysfunction 1.8 0.3 5
Fibromyalgia 1.7 2 -0.18
Functional constipation / chronic idiopathic constipation 3.4 2.4 0.42
gallstone disease (gsd) 1.5 1.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.9 0.9 0
Generalized anxiety disorder 2.7 2.1 0.29
giant cell arteritis 0.3 0.3
Glioblastoma 0.9 -0.9
Gout 3 0.8 2.75
Graves' disease 2.4 1.1 1.18
Gulf War Syndrome 1.4 0.6 1.33
Halitosis 1.1 1.1
Hashimoto's thyroiditis 2.3 3 -0.3
Heart Failure 3.2 2.1 0.52
hemorrhagic stroke 0.6 0.5 0.2
Hidradenitis Suppurativa 1.4 1.4
High Histamine/low DAO 0.5 -0.5
hypercholesterolemia (High Cholesterol) 0.9 0.9
hyperglycemia 1.4 1.9 -0.36
Hyperlipidemia (High Blood Fats) 2 0.8 1.5
hypersomnia 1.1 1.3 -0.18
hypertension (High Blood Pressure 4 4.6 -0.15
Hypothyroidism 1.9 1.5 0.27
Hypoxia 0.8 0.9 -0.13
IgA nephropathy (IgAN) 2.3 2 0.15
Inflammatory Bowel Disease 4.1 3.7 0.11
Insomnia 3.2 1.5 1.13
Intelligence 1.2 0.9 0.33
Intracranial aneurysms 0.7 0.3 1.33
Irritable Bowel Syndrome 6.2 3.4 0.82
ischemic stroke 1.1 2.9 -1.64
Juvenile idiopathic arthritis 0.3 -0.3
Liver Cirrhosis 4.4 2.4 0.83
liver fibrosis 0.5 -0.5
Long COVID 3.2 6.1 -0.91
Low bone mineral density 0.5 0.5 0
Lung Cancer 1.6 0.5 2.2
Lymphoma 0.5 0.5
Mast Cell Issues / mastitis 0.5 1.4 -1.8
ME/CFS with IBS 1 -1
ME/CFS without IBS 0.9 0.5 0.8
membranous nephropathy 0.6 0.6
Menopause 1.1 1.1
Metabolic Syndrome 6.3 4.6 0.37
Mood Disorders 7.4 6.5 0.14
multiple chemical sensitivity [MCS] 0.5 -0.5
Multiple Sclerosis 1.8 3.4 -0.89
Multiple system atrophy (MSA) 1.5 -1.5
myasthenia gravis 1.3 1.3
neuropathic pain 0.5 1 -1
Neuropathy (all types) 0.3 0.8 -1.67
neuropsychiatric disorders (PANDAS, PANS) 0.3 0.6 -1
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 5 3.4 0.47
NonCeliac Gluten Sensitivity 0.7 1.1 -0.57
Obesity 6.8 6.7 0.01
obsessive-compulsive disorder 3.2 2.1 0.52
Osteoarthritis 1.9 1 0.9
Osteoporosis 2.7 1.3 1.08
pancreatic cancer 0.7 0.3 1.33
Parkinson's Disease 3.8 6.9 -0.82
Peanut Allergy 0.8 0.3 1.67
Polycystic ovary syndrome 5 3.8 0.32
Postural orthostatic tachycardia syndrome 0.5 0.5
primary biliary cholangitis 0.6 0.4 0.5
Primary sclerosing cholangitis 0.5 0.8 -0.6
Psoriasis 1.6 1.7 -0.06
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 4.4 2.9 0.52
Rosacea 0.3 0.5 -0.67
Schizophrenia 5 2.2 1.27
scoliosis 1 0.9 0.11
sensorineural hearing loss 1.1 -1.1
Sjögren syndrome 0.9 1.9 -1.11
Sleep Apnea 1 0.5 1
Slow gastric motility / Gastroparesis 0.9 0.4 1.25
Small Intestinal Bacterial Overgrowth (SIBO) 1.1 1.1
Stress / posttraumatic stress disorder 1.1 1.4 -0.27
Systemic Lupus Erythematosus 3.2 2 0.6
Tic Disorder 1.1 0.9 0.22
Tourette syndrome 0.8 1.2 -0.5
Type 1 Diabetes 3.1 2.4 0.29
Type 2 Diabetes 6.1 2.8 1.18
Ulcerative colitis 3.5 4.6 -0.31
Unhealthy Ageing 2.6 0.4 5.5
Vitiligo 1.5 0.9 0.67

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]